Angiodynamics to report fiscal 2022 first quarter financial results on september 30, 2021

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it will report financial results for the first quarter of fiscal year 2022 before the market open on thursday, september 30, 2021. the company's management will host a conference call at 8:00 a.m. et the same day to discuss the results. to participate in the conference call, di
ANGO Ratings Summary
ANGO Quant Ranking